Description
Creative Biolabs offers several bioanalysis and inhibitor screening assay kits for customers, which will help researchers to accelarate the studies in immunology and onconology areas. Durvalumab ELISA has been especially developed for the quantitative analysis of free Durvalumab in serum and plasma samples. Durvalumab ELISA is optimized with Imfinzi(R). Solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle.
Features
Available to study immunology signaling pathway, monitor and screen small molecular.
Applications
The kit can be used for the quantitative analysis of free Durvalumab in serum and plasma samples.
Research Areas
Cell Signaling Pathway, Immunology, Onconology
Datasheet